Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Extension Study
NCT00096967Phase 3Completed
- Sponsor
- Genentech
- Start
- Oct 2002
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in breast cancer, colorectal cancer (CRC), sponsored by Genentech. Started Oct 2002; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00096967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096967.